共 50 条
- [31] The role of IL-6 and STAT3 in inflammation and cancerEUROPEAN JOURNAL OF CANCER, 2005, 41 (16) : 2502 - 2512Hodge, DR论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Res Ctr, Cytokine Mol Mechanisms Sect, Lab Mol Immunoregulat, Frederick, MD 21702 USAHurt, EM论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Res Ctr, Cytokine Mol Mechanisms Sect, Lab Mol Immunoregulat, Frederick, MD 21702 USAFarrar, WL论文数: 0 引用数: 0 h-index: 0机构: NCI, Canc Res Ctr, Cytokine Mol Mechanisms Sect, Lab Mol Immunoregulat, Frederick, MD 21702 USA
- [32] Inhibition of IL-6/Jak/Stat3 signaling: a novel and potent targeting therapy for lung cancerCANCER RESEARCH, 2011, 71Gao, Sizhi P.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAMao, Ninghui论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USASchori, Erez论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USALiu, Shuhui论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USADaly, Laura论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USABarlas, Afsar论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAGueorguiev, Volodia D.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAZhao, Huiyong论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAQiu, Juan论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAHefter, Blake论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USARegales, Lucia论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAChmielecki, Juliann论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Nashville, TN 37235 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USAPao, William论文数: 0 引用数: 0 h-index: 0机构: Vanderbilt Univ, Nashville, TN 37235 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USABromberg, Jacqueline F.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
- [33] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 PathwayChinese Journal of Integrative Medicine, 2022, 28 (06) : 524 - 530ZHENG Chun-lei论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityHOU Ke-zuo论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityWANG An-qi论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityFANG Wan-xia论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityYU Shi-tong论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityLIANG Jin-e论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityQI Hai-yan论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityQU Xiu-juan论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityLIU Yun-peng论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical UniversityCHE Xiao-fang论文数: 0 引用数: 0 h-index: 0机构: Department of Medical Oncology, the First Hospital of China Medical University Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province, the First Hospital of China Medical University Liaoning Province Clinical Research Center for Cancer Department of Medical Oncology, the First Hospital of China Medical University
- [34] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 PathwayChinese Journal of Integrative Medicine , 2022, (06) : 524 - 530ZHENG Chunlei论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详HOU Kezuo论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详WANG Anqi论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详FANG Wanxia论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详YU Shitong论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详LIANG Jine论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详QI Haiyan论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详QU Xiujuan论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详LIU Yunpeng论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详CHE Xiaofang论文数: 0 引用数: 0 h-index: 0机构: 不详 Department of Medical Oncology, the First Hospital of China Medical University 不详 不详
- [35] Kang-Ai Injection Inhibits Gastric Cancer Cells Proliferation through IL-6/STAT3 PathwayChinese Journal of Integrative Medicine, 2022, 28 : 524 - 530Chun-lei Zheng论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyKe-zuo Hou论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyAn-qi Wang论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyWan-xia Fang论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyShi-tong Yu论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyJin-e Liang论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyHai-yan Qi论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyXiu-juan Qu论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyYun-peng Liu论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical OncologyXiao-fang Che论文数: 0 引用数: 0 h-index: 0机构: The First Hospital of China Medical University,Department of Medical Oncology
- [36] AT7519 against lung cancer via the IL6/STAT3 signaling pathwayBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 609 : 31 - 38Zhou, Feng论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaZhu, Fanyun论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaZhu, Tianru论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaZhao, Zhucheng论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaLi, Luyao论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaLin, Shichong论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaZhao, Haiyang论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Univ, Inst Life Sci, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaYang, Lehe论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaZhao, Chengguang论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaWang, Liangxing论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaLi, Jifa论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Yueqing Hosp, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R ChinaHuang, Xiaoying论文数: 0 引用数: 0 h-index: 0机构: Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China Wenzhou Med Univ, Affiliated Hosp 1, Wenzhou, Zhejiang, Peoples R China
- [37] Oroxylin A Inhibits Colitis-associated Carcinogenesis Through Modulating the IL-6/STAT3 Signaling PathwayINFLAMMATORY BOWEL DISEASES, 2013, 19 (09) : 1990 - 2000Yang, Xi论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaZhang, Fengyi论文数: 0 引用数: 0 h-index: 0机构: Nanjing Pukou Hosp, Dept Pharm, Nanjing, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaWang, Yajing论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaCai, Min论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaWang, Qing论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Wuxi Hosp Affiliated 2, Dept Neurosurg, Wuxi, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaGuo, Qinglong论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaLi, Zhiyu论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, Dept Med Chem, Sch Pharm, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R ChinaHu, Rong论文数: 0 引用数: 0 h-index: 0机构: China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China China Pharmaceut Univ, State Key Lab Nat Med, Dept Physiol, Nanjing 210009, Jiangsu, Peoples R China
- [38] Exploiting the STAT3 Nexus in Cancer-Associated Fibroblasts to Improve Cancer TherapyFRONTIERS IN IMMUNOLOGY, 2021, 12Allam, Amr论文数: 0 引用数: 0 h-index: 0机构: Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia Olivia Newton John Canc Res Inst, Heidelberg, Vic, AustraliaYakou, Marina论文数: 0 引用数: 0 h-index: 0机构: Olivia Newton John Canc Res Inst, Heidelberg, Vic, AustraliaPang, Lokman论文数: 0 引用数: 0 h-index: 0机构: Olivia Newton John Canc Res Inst, Heidelberg, Vic, AustraliaErnst, Matthias论文数: 0 引用数: 0 h-index: 0机构: Olivia Newton John Canc Res Inst, Heidelberg, Vic, AustraliaHuynh, Jennifer论文数: 0 引用数: 0 h-index: 0机构: Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia
- [39] The IL-6/JAK/STAT3 pathway: Potential therapeutic strategies in treating colorectal cancer (Review)INTERNATIONAL JOURNAL OF ONCOLOGY, 2014, 44 (04) : 1032 - 1040Wang, Shu-Wei论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Minimally Invas Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Dept Minimally Invas Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R ChinaSun, Yue-Ming论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Dept Minimally Invas Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China Nanjing Med Univ, Dept Minimally Invas Surg, Affiliated Hosp 1, Nanjing 210029, Jiangsu, Peoples R China
- [40] IL-22 produced by cancer-associated fibroblasts promotes gastric cancer cell invasion via STAT3 and ERK signalingBritish Journal of Cancer, 2014, 111 : 763 - 771H Fukui论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineX Zhang论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineC Sun论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineK Hara论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineS Kikuchi论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineT Yamasaki论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineT Kondo论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineT Tomita论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineT Oshima论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineJ Watari论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineJ Imura论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineT Fujimori论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineM Sasako论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal MedicineH Miwa论文数: 0 引用数: 0 h-index: 0机构: Hyogo College of Medicine,Division of Gastroenterology, Department of Internal Medicine